The T-20 peptide targets the HIV envelope glycoprotein, inducing dose- dependent reductions in plasma HIV RNA that are equivalent to those induced by existing drugs.
CITATION STYLE
Richman, D. D. (1998). Nailing down another HIV target. Nature Medicine. Presse Dienstleistungsgesellschaft mbH und Co. KG. https://doi.org/10.1038/3209
Mendeley helps you to discover research relevant for your work.